| Product Code: ETC9613309 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Apixaban Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Apixaban Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Apixaban Market - Industry Life Cycle |
3.4 Taiwan Apixaban Market - Porter's Five Forces |
3.5 Taiwan Apixaban Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.6 Taiwan Apixaban Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.7 Taiwan Apixaban Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Taiwan Apixaban Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Taiwan |
4.2.2 Growing awareness about the benefits of apixaban in stroke prevention |
4.2.3 Favorable government policies promoting the use of novel anticoagulants |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of apixaban |
4.3.2 Competition from existing anticoagulant drugs in the market |
4.3.3 Price volatility of apixaban impacting affordability for patients |
5 Taiwan Apixaban Market Trends |
6 Taiwan Apixaban Market, By Types |
6.1 Taiwan Apixaban Market, By Dosage Form |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Apixaban Market Revenues & Volume, By Dosage Form, 2021- 2031F |
6.1.3 Taiwan Apixaban Market Revenues & Volume, By Capsule, 2021- 2031F |
6.1.4 Taiwan Apixaban Market Revenues & Volume, By Tablets, 2021- 2031F |
6.2 Taiwan Apixaban Market, By End-Users |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Apixaban Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Taiwan Apixaban Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 Taiwan Apixaban Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.5 Taiwan Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Taiwan Apixaban Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Apixaban Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Taiwan Apixaban Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Taiwan Apixaban Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.5 Taiwan Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Apixaban Market Import-Export Trade Statistics |
7.1 Taiwan Apixaban Market Export to Major Countries |
7.2 Taiwan Apixaban Market Imports from Major Countries |
8 Taiwan Apixaban Market Key Performance Indicators |
8.1 Number of prescriptions for apixaban in Taiwan |
8.2 Patient adherence rate to apixaban therapy |
8.3 Rate of adverse events reported for apixaban use |
9 Taiwan Apixaban Market - Opportunity Assessment |
9.1 Taiwan Apixaban Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.2 Taiwan Apixaban Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.3 Taiwan Apixaban Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Taiwan Apixaban Market - Competitive Landscape |
10.1 Taiwan Apixaban Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Apixaban Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here